CURRICULUM VITAE
`
`Name:
`
`Barbara S. Giesser, M.D.
`
`Business Address: UCLA School of Medicine
`Reed Neurologic Research Center
`710 Westwood Plaza
`Los Angeles, Ca. 90095
`(310) 825-7313
`
`Citizenship:
`
`
`
`USA
`
`EDUCATION
`
`1968-1972 University of Miami, Coral Gables, FL
`1972-1974 University of Texas Graduate School of
`Biomedical Sciences at Houston, Tx.
`1974-1978 University of Texas Medical School, San Antonio M.D.
`
` B.S.
`
`M.S. (Virology)
`
`HOSPITAL TRAINING
`
`1978-1979 Montefiore Hospital, Bronx, New York
`1979-1982
`Bronx Municipal Hospital Center, Bronx, NY
`1982-1983
`Albert Einstein College of Medicine, Bronx, NY
`
` Medicine Intern
` Neurology Resident
` Fellow, Neurology
`
`LICENSURE
`
`1979
`1984
`1992
`2002
`
`New York
`New Jersey
`Arizona
`California
`
` 140361 (Active)
` MA44787 (Inactive)
` 20709 (Inactive)
` C 50803 (Active)
`
`BOARD CERTIFICATION
`
`1985
`1992
`
`Diplomate (Neurology), American Board of Psychiatry & Neurology
` Certified, American Society of Neurorehabilitation; re-certified, 1997, 2002
`
`PROFESSIONAL EXPERIENCE
`
`10/12-present Professor of Clinical Neurology UCLA
`7/07-9/12
` Clinical Professor of Neurology, UCLA
`9/02-present
` Medical Director, MS Achievement Center, UCLA
`7/02-present
` Clinical Director, MS Program, UCLA
`7/02-6/07
` Associate Clinical Professor of Neurology, UCLA
`4/98-6/02
` Medical Director for Neurology, Arizona Telemedicine Program
`2/93-6/02
` Associate Professor of Clinical Neurology, AHSC, Tucson
`12/91-6/95
` Medical Director, Rehabilitation Institute of Tucson
`1/92-1/93
` Clinical Lecturer in Neurology, AHSC, Tucson
`1988-1991
` Consultant staff, Burke Rehabilitation Center Mamaroneck, New York
`
`ARGENTUM EX1003
`
`Page 1
`
`

`

`
`
`
`
` Revised, March 16,2016
`
` Medical Director, Bernard Gimbel MS Comprehensive Care Center, Holy Name
`Hospital, Teaneck, NJ
`Assistant Professor of Neurology, Albert Einstein College of Medicine, Bronx NY
`
`
`1985-1990
`
`1983-1991
`
`1982-1991
`
`Attending Neurologist, Multiple Sclerosis Research
`and Training Center, Albert Einstein College of Medicine
`1982-1991 Attending Neurologist, Hospital of the Albert Einstein
`College of Medicine
`1981-1982 Staff physician, Headache Unit Montefiore Hospital,
` Bronx, NY
`
`
`PROFESSIONAL ACTIVITIES
`
`Committee and Educational Service (David Geffen UCLA School of Medicine)
`
`2003-pres. Member, GEC
`2004- 2006 Member QA Committee
`2004-2005 Neurology Clerkship Co-Director
`2005- 2006 Neurology Clerkship Director
`2005
` Member, Psychiatry Clerkship Review Committee
`2005 Dep’t. of Neurology Taxation Review Committee
`2006-pres. Vice Chair for Clinical & Educational Affairs, Dep’t of Neurology
`2007-2008 Neurology Clerkship Co- Director
`2007-2008 SOM Clinical Education Task Force
`2008-2011 Residency Selection Committee, DON
`2008-2011 Residency Training Committee, DON
`2008-pres
`Organizer & faculty, “Neurology for Psychiatrists” lecture series
`2009-2011
`Search Committees member, Neuromuscular, Epilepsy, Headache
`2009-2010 COM Science of Learning Symposium, planning committee & panel member
`2012-2015 DON Care Connect Committee
`2013-pres Member, DON In-pt. Oversight Committee
`2013-2015 DON Residency Selection Committee
`2013-2015 DON Residency Training Committee
`2012-2014 DON representative, FPG QI initiative
`2014, 2015 Co Facilitator: Teaching Humanism at the Bedside
`2014-pres
`Member, Clinical CAP Committee ( SOM)
`
`Committee Service (University of Arizona Health Sciences Center {AHSC})
`
` 1996-1997 Vice Chair, HCB Review Sub-Committee
`
`
` 1996-2000 COM Admissions Committee
`
`
` 1997-2002 Dep’t. of Neurology P&T Committee
` 1997-2002 Dep’t. of Neurology Resident Education Committee
` 1998-2002 COM Curriculum Committee
`
`
` 1999-2000 Chair, SBS Review Sub-committee
`
` 2000-2001 Dean’s Advisory Committee on Admissions
` 2000-2002 Chair, Electives Sub-Committee
` 2000-2001 Dean’s Committee on Women Faculty
` 2001-2002 Chair, HCB Review Sub-committee
`2001-2002 Vice-Chair, COM Curriculum Committee
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`Page 2
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`
`
`
`Community Service
`
`1992-2000 Board of Directors, Desert SW Chapter, National MS Society
`2002-2004 Professional Advisory Committee So. Cal. Chapter National MS Society
`2003- 2015. Board of Directors, So. Cal Chapter, National MS Society
`2003 Member, Strategic Long Term Planning Committee, So. Cal. Chapter, NMSS
`2004-2006 Chair, Professional Advisory Committee, So. Cal. Chapter, NMSS
`2016 Member, Healthcare Advisory Committee So Cal. Chapter NMSS
`
`Professional Societies
`
`1985-1993 Active member, American Academy of Neurology
`1987-1994 Active member, American Academy of Clinical Neurophysiology
`1993- Fellow, American Academy of Neurology
`2012- Fellow, American Neurological Association
`
`Professional Activities
`
`Chair, Scientific Session on Rehabilitation, 43rd Annual Meeting of the AAN (Boston)
`1991
`Member, Task Force on Gender Issues in Multiple Sclerosis. NMSS
`1997
`Principal author, “Compendium of Multiple Sclerosis Information, 2nd Edition.” NMSS
`1997
`1997-1999 Counselor, AAN Section on Multiple Sclerosis.
`1998-2000 Chair, Scientific Issues Committee, American Society of Neurorehabilitation
`1999
`Author, “Core Curriculum for MS” AAN Section on MS
`1999-2003 Chair, Client Education Committee, National MS Society (New York)
`1999-
`Advisory Panel, MS Women Neurologists Initiative
`1999-2005 Member, AAN Undergraduate Education Subcommittee
`1999- 2011 Chair, Education Committee, AAN Section on MS
`1999-2003 Member, Executive Committee, Medical Advisory Board, NMSS (New York)
`2000
`Grant Reviewer, Texas Higher Education Coordinating Board, Biomedicine Panel
`2002-pres
`Member, Selection Panel National MS Society Clinical Fellowship in MS
`2003
`Member, Clinical Expert Panel, MS Quality Indicators Project, National MS Society (NY)
`2003-
`Invited Member, MS Forum
`2003-2005 Member, Client Education Committee, National MS Society (New York)
`2003-2009 Member, Professional Education Committee, National MS Society (New York)
`2003-
`Member, Medical Advisory Board, National MS Society ( New York)
`2004
`
`Chair, Quintessentials module on Multiple Sclerosis (AAN)
`2005-2007
`Editor in Chief, Initiatives newsletter( Publication of the Women Neurologist’s MS Initiative)
`2007-2008 Member, Neuroscience Question Writing Task Force, NMBE (Part ll) ( Philadelphia)
`2009-2011 Chair, Professional Education Committee National MS Society ( New York)
`2009
`
`Delegate, AAN “Neurology on the Hill”( Washington D.C.)
`2009
`
`Member, NIH review panel
`2012-2015 Member, NMSS Patient Management, Care and Rehabilitation peer review study section
`2012
`
`Member, NIH Expert review panel for PROMIS®
`2012-2014 Chair, Client Education Committee National MS Society ( New York)
`
`
`
`
`
`
`
`3
`
`Page 3
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`NMSS Wellness Task Force, Co-Chair( Dallas November, 2014)
`2014-
`AAN MS Quality Measures Development Work Group( Minneapolis)
`2014
`
`NMSS Public Policy Forum ( Washington DC, March 2015)
`2015
`
`Member, General Neurology Topic Work Group AAN( Minneapolis)
`2015
`Member, General Neurology Topic Work Group AAN( Minneapolis)
`2016
`
`2016-2017 Chair, Clinical Fellowship Committee NMSS
`
`Editorial Service
`
` Ad Hoc Reviewer, Archives of Internal Medicine
`1999
`
`Editorial Board, MS Quarterly Report
`2003
`2005 Ad Hoc Reviewer, J. Rehabilitation Research & Development
`2006
`
`Ad Hoc Reviewer, Neurology, Neurorehabilitation & Neural Repair
`2008
`
`Ad hoc reviewer, Archives of PM.&R, Continuum(AAN)
`2010
`
`Ad hoc reviewer, Int. J. of MS Care, Neurorehabilitation & Neural Repair
`2011
`Ad hoc reviewer, JRR&D, Neuropsychiatric Disease & Rx.
`
`2013
`Ad hoc reviewer, Exp Rev OB/Gyn, J. of Medical Internet Research, Neurology
`Exp. Rev. Clin. Immunology
`Ad hoc reviewer, JRR&D, Neurorehabilitation. & Neural Repair
`Editorial board, Neurology Now ( AAN)
`Guest Editor, “Sex Differences in the Study of Neurological Illnesses” Behavioral
`Neurology Vol 2015
`
`2014
`
`2015-
`2015
`
`
`AWARDS
`1982
`
`1992
`1995
`1995
`1995
`
`1996
`1997
`1997
`
`
`
`
`
`
`
`
`Leo Davidoff Society Award for Excellence in Housestaff Teaching (Albert
`Einstein Coll. Med)
`DOVE Award, Desert Southwest Chapter, National MS Society
`AHSC, Dean’s List Award for Excellence in Teaching in Clinical Sciences
`AHSC, Dean’s Teaching Scholar
`Community Education Volunteer of the Year, Desert Southwest Chapter
`National MS Society
`Teacher of the Year, Neurology Department, AHSC
`Award for Outstanding Research in Medical Education, WGEA
`Virginia and Vernon R. Furrow Grant Award for Innovations in
`Educational Technology
`Dedication Award, Desert Southwest Chapter, National MS Society
`
`1998
`1997-2006 Who’s Who in the World
`1997-2008 Who’s Who in Medicine & Healthcare
`1998-2008 Who’s Who in America
`2000
`
`Dedication Award, Desert Southwest Chapter, National MS Society
`2001
`
`Dedication Award, Desert Southwest Chapter, National MS Society
`2001
`Volunteer Appreciation Award, Desert Southwest Chapter, National MS Society
`2002, 2011 AB Baker Section (AAN) Teaching Recognition Certificate
`2003 Sylvia Lawry Founder of the Year Award So. Cal. Chapter, National MS Society
`2004 Hall of Fame Inductee National Multiple Sclerosis Society
`2005, 2007, 2009, 2011,2013,2014,2015,2016 Best Doctors in America
`2009
`“Teaching Humanism at the Bedside” Award ( David Geffen UCLA School of Medicine)
`
`
`
`
`
`
`
`4
`
`Page 4
`
`

`

`
`2010
`
`
`
`
`
` Revised, March 16,2016
`
`Serge & Yvette Dadone Award for Excellence in Clinical Teaching ( David Geffen
`UCLA SOM)
`Elected to American Neurological Association
`RRUCLAMC “Exceptional Physician” Award
`
`
`
`
`2012
`2016
`
`GRANTS
`1987-1988 National Multiple Sclerosis Society ($8,300) PI: Evoked Potentials &Cognition in MS
`1989-1991 National Multiple Sclerosis Society ($287,000) PI: Longitudinal Study of Evoked
`Potentials and Cognition in MS
`Eastern Paralyzed Veterans Association ($33,000) PI: Use of the Levo-Chair in MS
`1990-1991
`1997-1998 National Multiple Sclerosis Society ($26,000) PI: Neurologic Status and the Menstrual
`
`
`Cycle in MS
`2003-2004 National Multiple Sclerosis Society ($44,000): PI: Locomotor Training Using Body Weight
`Support on a Treadmill in Persons with MS
`2006-2009 National Multiple Sclerosis Society ($602,689) PI: Robotic locomotor training in persons with
` MS
`2002-2008 National MS Society, Harry Weaver Junior Faculty Award, ($512,867) Co- I.
`“The Onset of Progressive MS: Structural and Functional Determinants (NL
`Sicotte, PI)
`2005-2010 National Multiple Sclerosis Society ($825,000) Co-investigator (R. Voskuhl PI).
` “A Collaborative MS Research Center Award: Neuroprotection in EAE/MS”
`
`2007-2013 National MS Society, NIH($ 4,768,091) Co-Investigator(R. Voskuhl, PI)
`A Combination Trial of Copaxone Plus Estriol in RRMS.
`2007-2009 National MS Society ($392,350) Co-investigator: (NL Sicotte, PI)
`Hippocampal volume loss in MS: Clinical consequences
`2007-2010 National MS Society($487,973) Co-investigator: ( B. Vickrey, PI)
`Development of Indicators for Multiple Sclerosis.
`2009-2013 National MS Society($560,819) PI: “Exercise as a strategy to treat cognitive
` dysfunction in persons with MS”
`2013-2014 National MS Society ($44,000) PI: Cooling strategies in persons with MS
`2014-2015
`AUPN ( $100,000) Co-PI( C.Flippen, PI): Educational grant: The NERVE
`project: videotaping the resident neurologic examination
`
`
`
`
` CLINICAL TRIALS
`
`1998-1999 Site PI: A double blind, placebo controlled dose determination safety, tolerability
`and efficacy study of intravenous Antegren in patients with MS during an acute attack.
`
`1999-2001 Co-Investigator: The CORAL Study: A multinational, multicenter, randomized
`double blind, placebo controlled study to evaluate the effect of 2 doses of glatiramer acetate
`administered orally in R/R MS patients.
`
`2002-2005 Co-investigator: (R Voskuhl, PI): Trial of Testosterone Treatment for
`Multiple Sclerosis
`
`2006-2009 PI: Locomotor training in persons with Multiple Sclerosis
`
`
`
`
`
`
`
`
`5
`
`Page 5
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`2007-2013 Co-investigator, Site PI ( R. Voskuhl PI)A multicenter, double blind, randomized,
`placebo controlled combination trial of Copaxone plus estriol in relapsing remitting MS
`
`2011-2012 Co-investigator (R. Voskuhl, PI) Randomized, controlled combination trial of estriol
`to treat cognitive impairment in women with MS
`
`2009-2014 PI: Exercise as a strategy to treat cognitive dysfunction in persons with MS
`
`2013-2014 PI: Cooling strategies in persons with MS
`
`LECTURES and PRESENTATIONS
`
`Invited Presentations
`
`1.“Evoked potentials as outcome measures.” Presented at the 7th Annual Meeting of the MS
`Consortium, Halifax, Nova Scotia, (June 1991).
`2.“Event related potentials in MS patients: Neuropsychologic and MRI correlates.” Presented at
`the workshop on Neurobehavioral Dysfunction in MS, Bergamo, Italy, (June, 1992).
`3.“Dysphagia in Multiple Sclerosis.” Presented at ASHA, San Antonio, Tx. (November 1992)
`4.“Gender differences in Neurologic Autoimmune Disease.” Presented at the Healthy Women
`2000 Conference, USPHS, Washington, D.C., (June 1996).
`5.“Neurorehabilitation of MS” Neurology Grand Rounds, Univ. of Maryland, Baltimore( Feb. 2001)
`6. “Update on MS” California Pharmacists Association Annual Meeting Anaheim, (March 2003)
`7. Keynote Speaker, Annual MS Meeting, MS Society of Australia Melbourne( June, 2003)
`8. Presentation, “Integrating Wellness into the Medical Model of MS Care” 22nd Annual Meeting of
`the CMSC Washington DC (May, 2007)
`9. 18th annual Stanley Waterman Research Lecture:” Estriol & the promise of now: Emerging
`therapeutics for MS” Central NE Chapter, NMSS Newton, Mass. (March, 2008)
`10.Presentation to PREP program pre-med students, (May, 2009)
`11. “Robotic Rehabilitation Experience in MS” First International Transformational Technology in
`Rehabilitation Summit (Downey, CA. September, 2010)
`12. Keynote Speaker, 2011 AAMC White Coat Ceremony, UCLA ( Los Angeles, Ca August 2011)
`13. Keynote Speaker, NMSS Annual Research Symposium New York, (September 2011)
`
`CME Course Faculty
`
`1.Chair, “Neurology for Non-Neurologists” 2nd World Congress of Neurorehabilitation
`Toronto (April,1999)
`2.Faculty,“Women’s Issues in MS” Univ. of So. Fla. Office of Continuing Education
`Santa Fe, NM (July 2000)
`3. Faculty” Gender Issues in MS” AAN 53rd Annual Meeting Philadelphia, (May, 2001)
`4. Faculty, “Fatigue & Spasticity in MS” Third Annual Current Topics in the Treatment of MS
`Univ. of So. Fla. Office of Continuing Education Asheville, NC (November, 2001)
`5.Faculty,” Gender Issues in MS” ASNR Course: Integrating New Advances into the
`Medical and Rehabilitative Treatment of MS. Reno, Nevada (November, 2001)
`6.Chair,” Integrating Wellness into MS Management” Los Angeles (March, 2003)
`7.Director, “Practical Symptom Management in MS” Course at 55th annual meeting AAN,
`Honolulu (April 2003)
`8.Co-chair, “Update on MS and Parkinson’s Disease” Los Angeles (September, 2003)
`
`
`
`
`
`
`
`6
`
`Page 6
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`9.Chair, “Integrating Wellness into MS Management” Los Angeles, (March, 2004)
`10.Faculty, Consortium of MS Centers “Multiple Sclerosis Preceptorship” Los Angeles
`(October, 2004)
`11.Chair, “Integrating Wellness in MS Management” Los Angeles, (March 2005)
`12.Faculty, “Update on Management of MS and Movement Disorders”
`Neurology Residents & Fellows Forum UCSD Dep’t. of Neurosciences ANA San Diego,Ca.
`(September,2005)
`13.Chair, “Innovations in Managing Chronic Neurologic Disease” Los Angeles, (March 2006)
`14.Faculty, “Advances in MS And Sleep Medicine” Dinner for UCLA DON Voluntary Faculty
`Los Angeles (April 2007)
`15. Presentation, “Integrating Wellness into the medical model of MS Care” 22nd CMSC
`Annual meeting Washington DC ( May, 2007)
`16.Speaker, Grand Rounds, “New Approaches to Multiple Sclerosis” Century City Medical
`Center Los Angeles (June, 2007)
`17. Co-Chair,”Complimentary Approaches to Wellness in Chronic Neurologic Disease” Los
`Angeles, (October, 2007)
`18.Faculty, “Optimizing Management of Neurological Disorders” Los Angeles, (Nov. 2007)
`19.Co- Chair, “Neurology for Non-Neurologists” Los Angeles (March 2008)
`20.Speaker, UNLV Dep’t. of Medicine Grand Rounds, “Update on MS” Las Vegas (April 2008)
`21.Faculty, Family Practice Update:” Diagnosis & Treatment of MS” Los Angeles, (May,2008)
`22.Co-Chair, “Neurology for Non-Neurologists” Los Angeles, (March 2009)
`23.Neurology Grand Rounds, Cedars-Sinai Medical Center ”New Treatments for MS”
` Los Angeles, (May 2009)
`24.Neuroscience Grand Rounds Harbor UCLA Medical Center” Symptom management in MS’
` ( Nov.,2009)
`25.Co Chair, “Complementary & Alternative Medicine in Neurology” UCLA Extension (May
`2010)
`26. Discussant, Grand Rounds: “CPC: Optic Neuritis” UCLA Dept’. of Neurology (Sept. 2010)
`27. Speaker, Provident St. Joseph Medical Center Grand Rounds, ”Update on MS” (Burbank,
`May, 2011)
`28. Speaker, Neuroscience Grand Rounds, Harbor UCLA: “Updates on MS” ( March 2012)
`29. Faculty, “Updates on Multiple Sclerosis” UCLA DON Voluntary Faculty Dinner Los
`Angeles (April 2012)
`30. Presentation, “Wellness models in MS” 27th Annual meeting of Consortium of MS Centers
`San Diego, Ca. ( June 2012)
`31.Director, “Integrative Management of MS” course at 65th AAN Annual meeting ( San Diego,
`Ca. (March 2013)
`32.Faculty, Ist Annual UCLA Review of Clinical Neurology: “Multiple Sclerosis” ( Los Angeles,
`September 2013)
`33. Faculty, Current Strategies in the Diagnosis & Treatment of MS, “Therapeutic Applications
`of Exercise for Persons with MS” (Jersey City, NJ Sept. 2013)
`34. Speaker, “Optimizing the use of DMD in MS” California Neurologic Society (Monterey,Ca.
`Oct.2013)
`35. Grand Rounds Semel Neuropsychiatric Institute: “Comprehensive Management of Persons
`with MS ( Los Angeles February 2014)
`36. Director, “Integrative Management of MS” course at 66th AAN Annual meeting
`( Philadelphia, Pa. April, 2014)
`37. Director, ”Gender Issues in MS” 29th CMSC Annual meeting(Dallas, May, 2014)
`38. Co Chair, 2ndannual UCLA Review of Clinical Neurology ( Los Angeles,September 2014)
`
`
`
`
`
`
`
`7
`
`Page 7
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`39. Faculty, “Current & emerging treatment options in MS” 10th annual Johns Hopkins MS
`Symposium (Sacramento, January 2015)
`40. Director, “Symptom management in MS” 67 AAN annual meeting ( Wash.D.C, Apr.2015)
`41. Co-Chair: 3rd Annual UCLA Review of Clinical Neurology ( Los Angeles, September,2015)
`42. Faculty, “Symptom Management in MS” 68th AAN annual meeting( Vancouver, BC April
`2016)
`
`FACULTY/RESIDENT MENTOR
`
`Dr. Callene Momtazee 2005-2006
`Dr. Indu Subramanian 2008-2011
`Dr. Leah Ngiemphieu 2008-2013
`Dr. Lara Schrader 2010-2013
`Dr. Justin Cheongsiatmoy 2011-2014
`Dr. Matthew Tremblay 2012-2014
`Dr. Marwa Kaisey 2013-2017
`Dr. Nicholas Parziale 2014-2016
`Dr. Katherine Podraza 2016-2017
`Dr. Nasheed Jamal 2016-
`
`Other Teaching ( Geffen SOM)
`Neurology resident didactics ( MS lectures) 2003-present
`Third year clerkship lectures ( MS) 2003-2012
`Faculty:” Doctoring” 2003 2004
`Block 4 Neuroscience PBL facilitator, 2004, 2005, 2006
`Faculty, Clinical Fundamentals 2006
`Faculty, Clinical skills lab :1st year med students( 2008-2013)
`Mentor, Jennifer Danesh( 3rd yr medical student) Jan –May 2015
`Casebook facilitator( medical student clerkship) June/July 2016
`Mentor, PREP student ( July 2016)
`
`BIBLIOGRAPHY
`
`A.RESEARCH PAPERS-PEER REVIEWED
`
`1.Kopchick J, Harless J, Giesser B, et al. (1981). Endodeoxyribonuclease activity associated
`With Rauscher murine leukemia virus, Journal of Virology 37:274-278.
`2. LaRocca N, Scheinberg L, Slater R, Giesser,B, Smith C, Traugott U, et al. (1984)
`Field testing of a minimal record of disability in MS: the US and Canada. Acta Neurologica
`Scandinavica Supplementum 101: 126-138
`3.Giesser B, Kurtzberg D, Vaughan HG, Arezzo JC, Aisen M, Smith C, LaRocca N and
`Scheinberg LC. (1987). Trimodal evoked potentials compared with magnetic resonance
`imaging in the diagnosis of Multiple Sclerosis. Archives of Neurology, 44:281-294.
`4.Novak GP, Wiznitzer M, Kurtzberg D, Giesser B, and Vaughan H.(1988). The utility of visual
`Evoked potentials using hemifield stimulation and several check sizes in the evaluation of
`Suspected Multiple Sclerosis. Electroencephalography and Clinical Neurophysiology, 71:1-11
`5. Scheinberg L, Smith C, Giesser B, Traugott U, Aisen M, LaRocca N et al. Efficacy & toxicity
`of cyclosporine in chronic progressive MS: a randomized double blinded placebo controlled
`clinical trial. ( 1990) Ann. of Neurology 27(6) 591-605
`
`
`
`
`
`
`
`8
`
`Page 8
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`6.Smith CR, LaRocca N, Giesser B, and Scheinberg LC. (1991). High dose oral baclofen:
`Experience in patients with Multiple Sclerosis. Neurology, 41:1829-1830
`7.Giesser B,Schroeder MM, LaRocca N, Kurtzberg D, Ritter W, Vaughan HG, Scheinberg L.
`(1992)Endogenous event-related potentials as indices of dementia in Multiple Sclerosis
`patients
`Electroencephalography and Clinical Neurophysiology, 82:320-329
`8.Schroeder MM, Lipton RB, Ritter W, Giesser B, Vaughan HG. (1995) Event-related potential
`correlates of early processing in normal aging. International Journal of Neuroscience, 80(1-
`4):1-82.
`9.Ratzker PK, Feldman J, Scheinberg L, LaRocca NG, Smith CR, Giesser B, Aisen M(1996)
`Self assessment of neurologic impairment of MS. J. of Neurologic Rehab., 11:207-211
` 10.Kochler NK, Genain C, Giesser B, Hauser S. ( 2002) The human T cell response to
`myelin Oligodendrocyte glycoprotein: A Multiple Sclerosis family based study. J. Of
`Immunology 168 2-8
`11.Coyle PK, Christie S, Fodor P, Fuchs K ,Giesser B, Gutierriez A, Lynn J, Weinstock-
`Gutmann, B, Pardo L. (2004) Multiple Sclerosis gender issues: clinical practices of women
`neurologists. Multiple Sclerosis 10(5) 582-588
`12.Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez Bresnahan M, Stam-
`Moraga M, Chang P, Francis GS. ( 2005) Pregnancy outcomes during treatment with interferon
`beta 1a in patients with MS. Neurology 65(6) 802-806
`13. Giesser B, Beres-Jones J, Budovitch A, Herlihy E, Harkema S. (2007) Locomotor training
`improves mobility in persons with MS: A pilot study. Multiple Sclerosis 13 (2) 224-231
`14. Sicotte N, Giesser B,Tandon V, Klutch R,Steiner B, Drain A, Shattuck D, Hull L, Wang H,
`Elashoff R, Swerdloff R, Voskuhl R. (2007) Potential neuroprotective effects of testosterone
`Treatment in relapsing remitting MS. Arch. Of Neurology 64 (5) 683-688
`15.Sicotte NL, Kern K, Giesser B, Schultz A, Montag M, Vinters HV, Bookheimer SY.( 2007)
`Hippocampal abnormalities in multiple sclerosis: imaging and histopathological findings.
`Multiple Sclerosis 13(Suppl 2):S14,
`16. Cardinal KS, Wilson S, Giesser B, Drain AE, Sicotte NL. ( 2008) A longitudinal fMRI
`study of the PASAT. Multiple Sclerosis, 14 465-471
`17.Sicotte N,Kern K, Giesser B, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer
`S. (2008) Regional hippocampal atrophy in MS. Brain 131( pt.4) 1134-1141
`18. Hay, C, Strathmann C, Lieber E, Wick K, & Giesser B. (2008) Why patients go on line:
`MS, the internet, and physician patient communication. The Neurologist 14(6) 374-81
`19.Gold S, Chalifoux S, Giesser B, Voskuhl R. (2008) Immune modulation and increased
`neurotrophic factor production in MS patients treated with testosterone. J. Neuroinflammation
`5:32
`20. Gold S, Kern K, O’Connor M-F, Montag M, Kim A, Yoo YS, Giesser B,and Sicotte N.
`(2010) Smaller Cornu Ammonis 2–3/Dentate Gyrus Volumes and Elevated Cortisol in Multiple
`Sclerosis Patients with Depressive Symptoms. Biol. Psych 68(6) 553-559
`21. Cheng EM, Crandall CJ,. Bever C, Giesser B, Haselkorn J, Hays R, Shekelle P,
`Vickrey B. (2010) Quality Indicators for Multiple Sclerosis. Multiple Sclerosis 16 (8) 970-981
`22. Sicotte, N, Kern K, Sarcona J, Montag M, Giesser B. (2011)Corpus callosal diffusivity
`predicts motor impairment in relapsing-remitting multiple sclerosis: A TBSS and tractography
`Study Neuroimage 55(3) 1169-1177
`23. Kern K, Ekstrom A, Suthana N, Giesser B, Montag M, Arshnanpali A, Bookheimer S,
`Sicotte N. (2012) Fornix damage limits verbal memory functional compensation in MS.
`
`
`
`
`
`
`
`9
`
`Page 9
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`Neuroimage Feb 1;59(3):2932-40.
`24. Kurth F, Luders E, Sicotte NL, Gaser C, Giesser BS, Swerdloff RS, Montag MJ, Voskuhl RR,
`McKenzie-Graham AJ. (2014)Testosterone effects on gray matter density in men with multiple
`sclerosis: a voxel-based morphometry study. Neuroimage Clin. Mar 6;4:454-60.
`25. Voskuhl, R, Wang, H, Wu, TJ, Sicotte N,Nakamura K, Kurthn F, Itoh N, Bardens J,
`Bernard J, Corboy J, Cross A, Dhib-Jalbut S, Ford, C, Frohman, E, Giesser B, et al. Estriol
`combined with glatiramer acetate for women with relapsing remitting MS: a randomized,
`placebo controlled phase 2 trial. (2015) The Lancet
`26.Robert J. Fox , Christopher S. Coffey Merit E. Cudkowicz , Trevis Gleason Andrew
`Goodman ,Eric C. Klawiter , KazukoMatsuda, Michelle McGovern Robin Conwit , Robert
`Naismith ,Akshata Ashokkumar , Robert Bermel , Dixie Ecklund , Maxine Koepp, Jeffrey Long
`Sneha Natarajan ,Srividya Ramachandran , Thomai Skaramagas Brenda Thornell Jon
`Yankey , Mark Agius ,Khurram Bashir , Bruce Cohen Patricia Coyle Silvia Delgadon, Dana
`Dewitt Angela Flores, Barbara Giesser, et al. Design, rationale, and baseline characteristics
`of the randomized double-blindphase II clinical trial of ibudilast in progressive multiple
`sclerosis(2016).
`Cont. Clinical Trials 50 166-177
`
`B. RESEARCH PAPERS-PEER REVIEWED (IN PRESS)
`NONE
`
`C. RESEARCH PAPERS-PEER REVIEWED (SUBMITTED)
`Giesser B, Herlihy E, Plummer D’Amato P, West M, Budovitch A, Pokras N, et al. Randomized
`controlled trial of robotic locomotor training in persons with MS.( in revision)
`
`D. RESEARCH PAPERS-NON-PEER REVIEWED
`NONE
`
`E. RESEARCH PAPERS-NON-PEER REVIEWED (IN PRESS)
`NONE
`
`F. RESEARCH PAPERS-NON-PEER REVIEWED (SUBMITTED)
`NONE
`
`
`
`CHAPTERS
`
`1.Scheinberg LC, Kalb R, LaRocca N, Giesser B, Slater R and Poser C. The doctor-patient
`relationship in Multiple Sclerosis. In: The Diagnosis of Multiple Sclerosis C Poser, L.
`Scheinberg, Eds. New York; Thieme-Stratton, Inc. pp 205-215 (1984).
`2.Scheinberg LC, and Giesser B. Drug Therapy. In: Multiple Sclerosis: A Guide for Patients
`and Families, 2nd Edition. L Scheinberg and N Holland, Eds. New York: Raven Press.
`pp. 53-66 (1987).
`3.Simmons JQ and Giesser B. Treatment with diet ibid pp 67-78(1987).
`4.Giesser B and Holtzer M. Wheelchairs, walkers, canes, and other aids. In: Orthotics in
`Neurologic Rehabilitation Mindy Aisen, Ed. New York: Demos Press, pp 131-146 (1992)
`5. Giesser, B. “Multiple Sclerosis” In: Current Diagnosis and Treatment of Women
`
`
`
`
`
`
`
`10
`
`Page 10
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`Dawn Lemcke, Julie Pattison, Lorna Marshall, Rebecca Cowley, Eds. New York McGraw Hill
`pp.402-410 (2003)
`6. Giesser,B. “Botulism” In: Lynn, DJ, Newton, HB, Rae-Grant AD, Eds. The 5-Minute
`Neurology Consult Philadelphia, Pa. Lippincott, Williams & Wilkins pp.80-81(2004)
`7. Giesser,B. “Trichinosis “ In: : Lynn, DJ, Newton, HB, Rae-Grant AD, Eds. The 5-Minute
`Neurology Consult Philadelphia, Pa. Lippincott, Williams & Wilkins pp.424-425 (2004)
`8. Birk, K & Giesser B “Fertility, Pregnancy & Childbirth” in: MS: A Guide for Families, 3rd Ed.
`Rosalind Kalb, Ed. New York Demos Press, pp.81-92 ( 2006)
`9. Giesser B . “Immunosuppressive & Novel Therapies” in: Primer on MS B. Giesser, Ed.
`New York, Oxford University Press pp.349-368 ( 2011)
`10. Voskuhl R, and Giesser B. “Gender & Reproductive Issues” in: Primer on MS B. Giesser,
`Ed. New York, Oxford University Press pp.221-240 ( 2011)
`11. Giesser, B. Diagnosis of MS. In: “Multiple Sclerosis” Neurologic Clinics Emmanuelle
`Waubant, Ed. Philadelphia, W.B. Saunders pp.381-388 (2011)
`12.Giesser B, Benedetto-Anazi M, Werner M. Fertility, pregnancy childbirth and gynecologic
`care. In: MS: The questions you have the answers you need. Rosalind Kalb, Ed. New York
`Demos Health pp 269-282 (2011)
`13. Giesser, B. “Trichinosis “ In: : Lynn, DJ, Newton, HB, Rae-Grant AD, Eds. The 5-Minute
`Neurology Consult Philadelphia Lippincott, Williams & Wilkins (2011)
`14. Momtazee C & Giesser B. “Sex-Determined Issues in Multiple Sclerosis” in Multiple
`Sclerosis & Other CNS Demyelinating Diseases; pp67-76 Samkoff L & Goodman A, Eds.
`Wiley Blackwell (2014).
`15.Voskuhl R & Giesser B. “Gender & Reproductive Issues” in: Primer on MS B. Giesser, Ed.
`New York, Oxford University Press ( 2nd Ed.) pp259-282 (2016)
`16. Giesser,B. “Relapses , immunosuppressive and novel therapies” in: Primer on MS
`B. Giesser, Ed. New York, Oxford University Press ( 2nd Ed.) pp442-463 (2016)
`
`CHAPTERS (IN PRESS)
`NONE
`BOOKS
`
`1.Scheinberg LC, Giesser B and Schaumburg HH. Neurology Handbook, 2nd Edition. (1986).
`New York: Medical Examination Publishing Co.
`2.Giesser B, Aisen M and Scheinberg LC. Neurology Specialty Board Review Book, 3rd
`Edition. (1986). New York: Elsevier Publishing.
`3.Giesser B, Kanof P, Aisen M and Elkin R. Neurology Specialty Board Review Book, 4th
`Edition. (1996). Connecticut: Appleton & Lange
`4. Kalb R, Holland N, Giesser B. MS for Dummies (2007) Indianapolis: Wiley Publishing
`5. Giesser,B. ( Ed.) Primer on MS (2011) New York: Oxford University Press
`6. Kalb R, Giesser B, Costello K. MS for Dummies: Second edition (2012) Indianapolis: Wiley
`Publishing
`7. Thrower, B, Costello, K, Giesser B. Navigating Life with MS (2015) New York: Oxford
`University Press
`8.Giesser B(Ed.). Primer on MS ,Second Edition. (2016) New York: Oxford University Press
`
`
`
`
`
`
`
`
`
`11
`
`Page 11
`
`

`

`
`
`
`
` Revised, March 16,2016
`
`
`LETTERS TO THE EDITOR
`
`Giesser B. How I learned to stop worrying and love DNA. NEJM. (1978)
`
`Scheinberg LC & Giesser B. INH in MS. Neurology 34:134-135 ( 1984)
`Giesser B. Primary Lateral Sclerosis. Arch. Neurol. 46(11) 1166-7 (1989)
`
`REVIEWS
`
`1.Giesser B. Landry-Guillain-Barre Syndrome. (1983). Medical Times III, 87-90.
`2.Blaivas JG, Holland N, Giesser B, LaRocca N, Madonna M and Scheinberg LC.
`Multiple Sclerosis bladder: Studies and care. (1984)Annals of the New York Academy of
`Sciences, 436:328-346.
`3.Giesser B. Multiple Sclerosis: Current concepts in management. (1985) Drugs 29:88-95.
` 4.Giesser B. Evoked potentials as outcome measures in Multiple Sclerosis. (1993)
`Journal of Neurologic Rehabilitation, 7:99-104
`5.Aisen M, Rosen M, Dobkin B, Selzer M, Laven L, Wessell T, Giesser B, Sparr S
`Lennihan L. Position paper: ASNR Scientific Issues Committee. (1996)
`Journal of Neurologic Rehabilitation, 10:1-7
`6.Whitacre, CC, Reingold, SC, O’Looney, P and the Task Force on Gender, MS, and
`Autoimmunity. (1999). Science 283 1277-1278
`7. Giesser B. Gender Issues in MS. (2002) The Neurologist 8 (6) 351-356
`8. Giesser B. Reproductive issues in persons with MS. (2004) Del. J. of Med. 76(3) 125-8
`9. Giesser, B. Multiple Sclerosis: A review and update. ( 2006) Family Practice Recertification
`28(1) 47-55
`10. Giesser, B. Exercise Training in persons with MS. ( Dec. 2007) US Neurological Disease
`Vol. ll pp.37-39
`11. Ford, C, Halper J, Coyle P, Fox E, Giesser B, et al. Therapeutic decision making in MS:
`Best practice algorithms for the MS care practitioner. (Sept.2014) Int. J. of MS Care. 16
`(suppl.5)
`12. Giesser B. Exercise in the management of persons with MS. (2015)Ther. Adv in
`Neurologic Disease 8(3) 123-130
`
`EDITORIALS
`Attarian H, Brandes J, Dafer R, Gerard E & Giesser B. Sex differences in the Study of
`Neurological Illnesses. ( 2015) In: Behavioral Neurology Vol. 2015 ID 676531
`
`PAPERS IN PREPARATION (RESEARCH COMPLETED)
`NONE
`
`ABSTRACTS
`
`1.Giesser B, Kurtzberg D, Arezzo JC, Vaughan HG, Aisen MA, Smith C, Scheinberg LC.
`Trimodal evoked potentials compared with magnetic resonance imaging in the diagnos